Titre : Équivalence thérapeutique

Équivalence thérapeutique : Questions médicales fréquentes

Termes MeSH sélectionnés :

International Classification of Functioning, Disability and Health
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Équivalence thérapeutique : Questions médicales les plus fréquentes", "headline": "Équivalence thérapeutique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Équivalence thérapeutique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-04", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Équivalence thérapeutique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pharmacocinétique", "url": "https://questionsmedicales.fr/mesh/D010599", "about": { "@type": "MedicalCondition", "name": "Pharmacocinétique", "code": { "@type": "MedicalCode", "code": "D010599", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G07.690.725" } } }, "about": { "@type": "MedicalCondition", "name": "Équivalence thérapeutique", "alternateName": "Therapeutic Equivalency", "code": { "@type": "MedicalCode", "code": "D013810", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sean M Hays", "url": "https://questionsmedicales.fr/author/Sean%20M%20Hays", "affiliation": { "@type": "Organization", "name": "Summit Toxicology, LLC, Bozeman, MT, USA. Electronic address: shays@summittoxicology.com." } }, { "@type": "Person", "name": "Erik Arntzen", "url": "https://questionsmedicales.fr/author/Erik%20Arntzen", "affiliation": { "@type": "Organization", "name": "Department of Behavioral Science, Oslo Metropolitan University, Oslo 0167, Norway erik.arntzen@equivalence.net." } }, { "@type": "Person", "name": "Christopher R Kirman", "url": "https://questionsmedicales.fr/author/Christopher%20R%20Kirman", "affiliation": { "@type": "Organization", "name": "Summit Toxicology, LLC, Bozeman, MT, USA." } }, { "@type": "Person", "name": "Sanjay Kalra", "url": "https://questionsmedicales.fr/author/Sanjay%20Kalra", "affiliation": { "@type": "Organization", "name": "Department of Endocrinology, Bharti Hospital, Karnal, India." } }, { "@type": "Person", "name": "Laxmaiah Manchikanti", "url": "https://questionsmedicales.fr/author/Laxmaiah%20Manchikanti", "affiliation": { "@type": "Organization", "name": "Pain Management Centers of America, Paducah, KY and Evansville, IN" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Quality-of-life among women with breast cancer: application of the international classification of functioning, disability and health model.", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38362250", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyg.2024.1318584" } }, { "@type": "ScholarlyArticle", "name": "Content validity of the International Classification of Functioning, Disability and Health core set for knee dysfunction: a Delphi study.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35837751", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09593985.2022.2101037" } }, { "@type": "ScholarlyArticle", "name": "Application of the international classification of functioning, disability, and health in autism and attention-deficit hyperactivity disorder: A scoping review.", "datePublished": "2024-08-25", "url": "https://questionsmedicales.fr/article/39183470", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/13623613241272044" } }, { "@type": "ScholarlyArticle", "name": "Assessment of functioning in ADHD according to World Health Organization standards: First revision of the International Classification of Functioning, Disability and Health Core Sets.", "datePublished": "2024-02-02", "url": "https://questionsmedicales.fr/article/38308443", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dmcn.15865" } }, { "@type": "ScholarlyArticle", "name": "Disability after breast cancer surgery: Proposal of linkage between the International Classification of Functioning, Disability and Health and the Grocery Shelving Task Test.", "datePublished": "2023-10-15", "url": "https://questionsmedicales.fr/article/37839015", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/pri.2057" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques", "item": "https://questionsmedicales.fr/mesh/D010829" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes pharmacologiques et toxicologiques", "item": "https://questionsmedicales.fr/mesh/D002620" }, { "@type": "ListItem", "position": 4, "name": "Pharmacocinétique", "item": "https://questionsmedicales.fr/mesh/D010599" }, { "@type": "ListItem", "position": 5, "name": "Équivalence thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013810" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Équivalence thérapeutique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Équivalence thérapeutique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Équivalence thérapeutique", "description": "Comment évaluer l'équivalence thérapeutique ?\nQuels tests sont utilisés pour l'équivalence ?\nQuelles sont les normes d'évaluation ?\nQui réalise les évaluations d'équivalence ?\nQuels sont les critères d'inclusion ?", "url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=International+Classification+of+Functioning,+Disability+and+Health&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Équivalence thérapeutique", "description": "Quels symptômes indiquent une non-équivalence ?\nComment reconnaître une réaction allergique ?\nQuels signes d'inefficacité observer ?\nLes symptômes varient-ils selon les traitements ?\nQuels symptômes nécessitent un avis médical ?", "url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=International+Classification+of+Functioning,+Disability+and+Health&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Équivalence thérapeutique", "description": "Comment prévenir les erreurs de traitement ?\nQuelles sont les bonnes pratiques de prescription ?\nComment informer les patients sur l'équivalence ?\nQuels outils aident à la prévention des erreurs ?\nPourquoi est-il important de connaître l'équivalence ?", "url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=International+Classification+of+Functioning,+Disability+and+Health&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Équivalence thérapeutique", "description": "Quels traitements sont souvent équivalents ?\nComment choisir entre deux traitements équivalents ?\nLes traitements équivalents ont-ils les mêmes effets ?\nComment évaluer la sécurité des traitements ?\nLes traitements équivalents nécessitent-ils des doses différentes ?", "url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=International+Classification+of+Functioning,+Disability+and+Health&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Équivalence thérapeutique", "description": "Quelles complications peuvent survenir avec des traitements équivalents ?\nComment gérer les complications liées aux traitements ?\nLes complications sont-elles prévisibles ?\nQuels sont les signes d'une complication grave ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=International+Classification+of+Functioning,+Disability+and+Health&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Équivalence thérapeutique", "description": "Quels facteurs augmentent le risque d'échec thérapeutique ?\nComment l'adhérence au traitement affecte-t-elle l'équivalence ?\nLes antécédents médicaux influencent-ils l'équivalence ?\nQuels facteurs environnementaux jouent un rôle ?\nComment évaluer les facteurs de risque ?", "url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=International+Classification+of+Functioning,+Disability+and+Health&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'équivalence thérapeutique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des études cliniques comparatives et des méta-analyses." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour l'équivalence ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de bioéquivalence et des études de pharmacocinétique sont couramment utilisés." } }, { "@type": "Question", "name": "Quelles sont les normes d'évaluation ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les normes incluent des critères de sécurité, d'efficacité et de qualité des médicaments." } }, { "@type": "Question", "name": "Qui réalise les évaluations d'équivalence ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les agences de régulation, comme l'ANSM, et des chercheurs indépendants effectuent ces évaluations." } }, { "@type": "Question", "name": "Quels sont les critères d'inclusion ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la population cible, les indications et les méthodes de traitement." } }, { "@type": "Question", "name": "Quels symptômes indiquent une non-équivalence ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des effets indésirables ou une efficacité réduite peuvent signaler une non-équivalence." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent éruption cutanée, démangeaisons, et gonflement après administration." } }, { "@type": "Question", "name": "Quels signes d'inefficacité observer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'absence d'amélioration des symptômes après un traitement peut indiquer une inefficacité." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les traitements ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent provoquer des symptômes différents selon leur composition." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un avis médical ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves ou persistants après un traitement doivent être évalués par un médecin." } }, { "@type": "Question", "name": "Comment prévenir les erreurs de traitement ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vérification des prescriptions et l'éducation des patients sont essentielles." } }, { "@type": "Question", "name": "Quelles sont les bonnes pratiques de prescription ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des protocoles standardisés et vérifier les allergies des patients." } }, { "@type": "Question", "name": "Comment informer les patients sur l'équivalence ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Fournir des brochures et des consultations pour expliquer les options de traitement." } }, { "@type": "Question", "name": "Quels outils aident à la prévention des erreurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des logiciels de gestion des prescriptions et des alertes de sécurité peuvent aider." } }, { "@type": "Question", "name": "Pourquoi est-il important de connaître l'équivalence ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Cela permet de choisir le traitement le plus approprié et de réduire les coûts." } }, { "@type": "Question", "name": "Quels traitements sont souvent équivalents ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les génériques et les médicaments de marque pour la même indication sont souvent équivalents." } }, { "@type": "Question", "name": "Comment choisir entre deux traitements équivalents ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le choix dépend de la tolérance, du coût et des préférences du patient." } }, { "@type": "Question", "name": "Les traitements équivalents ont-ils les mêmes effets ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils doivent avoir des effets cliniques similaires, mais peuvent différer en effets secondaires." } }, { "@type": "Question", "name": "Comment évaluer la sécurité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La sécurité est évaluée par des études cliniques et des rapports d'effets indésirables." } }, { "@type": "Question", "name": "Les traitements équivalents nécessitent-ils des doses différentes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement, mais des ajustements peuvent être nécessaires selon le patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des traitements équivalents ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des réactions allergiques ou des interactions médicamenteuses." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux traitements ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Il est crucial d'arrêter le traitement et de consulter un professionnel de santé." } }, { "@type": "Question", "name": "Les complications sont-elles prévisibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévisibles, surtout avec des antécédents médicaux." } }, { "@type": "Question", "name": "Quels sont les signes d'une complication grave ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes tels que des douleurs thoraciques ou des difficultés respiratoires sont alarmants." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et une communication ouverte avec le médecin sont essentiels." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'échec thérapeutique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, les comorbidités et l'adhérence au traitement influencent le risque." } }, { "@type": "Question", "name": "Comment l'adhérence au traitement affecte-t-elle l'équivalence ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise adhérence peut réduire l'efficacité, rendant l'équivalence difficile à évaluer." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils l'équivalence ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de réactions aux médicaments peuvent affecter le choix du traitement." } }, { "@type": "Question", "name": "Quels facteurs environnementaux jouent un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'alimentation, le mode de vie et l'exposition à des toxines peuvent influencer." } }, { "@type": "Question", "name": "Comment évaluer les facteurs de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation complète de l'historique médical et des habitudes de vie est nécessaire." } } ] } ] }

Sources (10000 au total)

Quality-of-life among women with breast cancer: application of the international classification of functioning, disability and health model.

This study aimed to identify the factors that influence Breast Cancer (BC) women's quality of life (QoL) based on the International Classification of Functioning, Disability and Health (ICF) framework... A cross-sectional study was conducted among 188 women with BC. The dependent variable, QoL, was measured using the Quality of Life Index (QLI-c). The independent variables were measured using the foll... There was a significant positive correlation between monthly income (... The ICF provided an excellent framework to explore the factors influencing QoL among women with BC. This study has given evidence for the relationship of demographic, clinical, and body functional fac...

Content validity of the International Classification of Functioning, Disability and Health core set for knee dysfunction: a Delphi study.

To assess the content validity of the preliminary core set for knee dysfunction based on the opinion of experts.... A panel of 180 experts in knee disorders or on the use of the International Classification of Functioning, Disability, and Health for musculoskeletal conditions was invited for this Delphi study. The ... Nineteen experts participated in all rounds. Of the 24 categories from the preliminary core set for knee dysfunction, 15 remained in the comprehensive core set and one category was further detailed in... After validation by experts, the comprehensive core set for knee dysfunction was composed of 25 categories that can be used to assess the functioning of patients with knee dysfunction....

Assessment of functioning in ADHD according to World Health Organization standards: First revision of the International Classification of Functioning, Disability and Health Core Sets.

To conduct the first revision of the World Health Organization International Classification of Functioning, Disability and Health (ICF) Core Sets for attention-deficit/hyperactivity disorder (ADHD).... A Delphi-like method was used, integrating evidence from stakeholder feedback and developing and piloting the ADHD ICF Core Set platform to inform revisions to the ADHD Core Sets.... A total of 27 second-level ICF codes were added to the comprehensive ADHD Core Set: body functions of temperament and personality, and basic sensory functions; activities and participation in terms of... Although substantially expanded, the revised ICF Core Sets better reflect the lived experience of individuals with ADHD and clinical implementation preferences than the initial sets. We recommend furt...

Disability after breast cancer surgery: Proposal of linkage between the International Classification of Functioning, Disability and Health and the Grocery Shelving Task Test.

To link the concepts measured by the Grocery Shelving Task Test (GST) to the codes and qualifiers of the activity and participation component of the International Classification of Functioning, Disabi... The linkage was performed by two professionals who applied the 10 standardized binding rules. The linking process was performed through the model of extraction and identification of the concepts that ... The GST test includes 1 domain of the activity and participation component (d4 mobility). The link with the qualifiers allowed quantifying the impairment of the limitations of activities in the postop... The linking of the GST to the ICF codes and qualifiers allowed quantifying the functional impairment in the postoperative period of breast cancer, allowing a comprehensive and standardized view, and b...

Body Function and Structure, Activity, and Participation Limitations of Lung Transplant Recipients Within the Scope of the International Classification of Functioning, Disability, and Health.

There is no study in the literature that specifically evaluates lung transplant recipients in the long-term under the framework of the International Classification of Functioning, Disability, and Heal... We evaluated 27 lung transplant recipients according to the International Classification of Functioning, Disability, and Health items in domain b (body functions), domain s (body structures), and doma... As the age of lung transplant recipients and the age at transplant increase, their sleep quality and respiratory functions decreased, and postural impairment increased. There was a negative correlatio... We found the International Classification of Functioning, Disability, and Health framework to be useful for the evaluation and for planning pulmonary rehabilitation for lung transplant recipients; it ...

Development of core sets for deafblindness using the International Classification of Functioning, Disability, and Health: the perspectives of individuals with lived experience.

The needs of people with deafblindness remain poorly understood and addressed globally. This study is part of a larger body of work to develop Core Sets for deafblindness using the International Class... To determine the perspectives on functioning of individuals with lived experience of deafblindness as they relate to the ICF.... Cross-sectional interview study.... Global, representing all six regions of the World Health Organization.... A diverse cohort of 72 individuals living with deafblindness or as close family members, ranging across the spectrum of severity.... Qualitative interviews and focus groups were used to explore six open-ended questions about perceived barriers and facilitators to functioning of body functions and structures, activities and particip... The analyses of the transcripts uncovered 2534 meaning units, leading to the identification of 492 corresponding distinct codes from the ICF framework, and spanning across 93.33% of coding categories ... Over 93% of the ICF classification categories were accessed to code the data provided by participants, demonstrating the complexity of functioning with deafblindness. This study provides valuable info... The inclusion of lived experience provides a holistic understanding of the daily challenges faced by individuals living with deafblindness. By being part of this process, they have a voice in shaping ...

The first step in developing an International Classification of Functioning, Disability and Health Core Set for Vision Loss: A systematic review.

As a first step in developing an International Classification of Functioning, Disability and Health (ICF) Core Set for adults with vision loss, this systematic review sought to identify the researcher... PubMed, Embase, CINAHL, APA PsycINFO and Web of Science were searched for studies on vision loss. Meaningful outcome measures and research topics were linked to the ICF components: environmental facto... After deduplication, 7219 records remained, of which 2328 articles were eligible for further review. For feasibility reasons, approximately 20% were randomly chosen from every publication year, result... The broad range of ICF categories identified in this systematic review represents the variety of functioning typical for adults with vision loss. These results reflect the focus of researchers over th...

International Classification of Functioning, Disability, and Health-based rehabilitation program promotes activity and participation of post-stroke patients.

The International Classification of Functioning, Disability, and Health (ICF) model has been applied in post-stroke rehabilitation, yet limited studies explored its clinical application on enhancing p... This study gathered evidence of the effects of an ICF-based post-stroke rehabilitation program (ICF-PSRP) in enhancing community reintegration in terms of ICF-A&P of post-stroke patients.... Fifty-two post-stroke patients completed an 8 to 12 weeks multidisciplinary ICF-PSRP after setting personal treatment goals in an outpatient community rehabilitation center. Intake and pre-discharge a... There were significantly higher levels in the ICF-BF and ICF-A&P domains, except cognitive function under the ICF-BF. Improvements in the primary outcomes predicted corresponding secondary outcomes. F... The ICF-PSRP was effective in promoting body function, and activity and participation levels of post-stroke patients. Positive treatment effects are characterized by goal-setting process, cross-domain...